Cargando…

The nicotine-degrading enzyme NicA2 reduces nicotine levels in blood, nicotine distribution to brain, and nicotine discrimination and reinforcement in rats

BACKGROUND: The bacterial nicotine-degrading enzyme NicA2 isolated from P. putida was studied to assess its potential use in the treatment of tobacco dependence. RESULTS: Rats were pretreated with varying i.v. doses of NicA2, followed by i.v. administration of nicotine at 0.03 mg/kg. NicA2 had a rap...

Descripción completa

Detalles Bibliográficos
Autores principales: Pentel, Paul R., Raleigh, Michael D., LeSage, Mark G., Thisted, Thomas, Horrigan, Stephen, Biesova, Zuzana, Kalnik, Matthew W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056991/
https://www.ncbi.nlm.nih.gov/pubmed/30041697
http://dx.doi.org/10.1186/s12896-018-0457-7
_version_ 1783341433656180736
author Pentel, Paul R.
Raleigh, Michael D.
LeSage, Mark G.
Thisted, Thomas
Horrigan, Stephen
Biesova, Zuzana
Kalnik, Matthew W.
author_facet Pentel, Paul R.
Raleigh, Michael D.
LeSage, Mark G.
Thisted, Thomas
Horrigan, Stephen
Biesova, Zuzana
Kalnik, Matthew W.
author_sort Pentel, Paul R.
collection PubMed
description BACKGROUND: The bacterial nicotine-degrading enzyme NicA2 isolated from P. putida was studied to assess its potential use in the treatment of tobacco dependence. RESULTS: Rats were pretreated with varying i.v. doses of NicA2, followed by i.v. administration of nicotine at 0.03 mg/kg. NicA2 had a rapid onset of action reducing blood and brain nicotine concentrations in a dose-related manner, with a rapid onset of action. A 5 mg/kg NicA2 dose reduced the nicotine concentration in blood by > 90% at 1 min after the nicotine dose, compared to controls. Brain nicotine concentrations were reduced by 55% at 1 min and 92% at 5 min post nicotine dose. To evaluate enzyme effects at a nicotine dosing rate equivalent to heavy smoking, rats pretreated with NicA2 at 10 mg/kg were administered 5 doses of nicotine 0.03 mg/kg i.v. over 40 min. Nicotine levels in blood were below the assay detection limit 3 min after either the first or fifth nicotine dose, and nicotine levels in brain were reduced by 82 and 84%, respectively, compared to controls. A 20 mg/kg NicA2 dose attenuated nicotine discrimination and produced extinction of nicotine self-administration (NSA) in most rats, or a compensatory increase in other rats, when administered prior to each daily NSA session. In rats showing compensation, increasing the NicA2 dose to 70 mg/kg resulted in extinction of NSA. An enzyme construct with a longer duration of action, via fusion with an albumin-binding domain, similarly reduced NSA in a 23 h nicotine access model at a dose of 70 mg/kg. CONCLUSIONS: These data extend knowledge of NicA2’s effects on nicotine distribution to brain and its ability to attenuate addiction-relevant behaviors in rats and support its further investigation as a treatment for tobacco use disorder.
format Online
Article
Text
id pubmed-6056991
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60569912018-07-30 The nicotine-degrading enzyme NicA2 reduces nicotine levels in blood, nicotine distribution to brain, and nicotine discrimination and reinforcement in rats Pentel, Paul R. Raleigh, Michael D. LeSage, Mark G. Thisted, Thomas Horrigan, Stephen Biesova, Zuzana Kalnik, Matthew W. BMC Biotechnol Research Article BACKGROUND: The bacterial nicotine-degrading enzyme NicA2 isolated from P. putida was studied to assess its potential use in the treatment of tobacco dependence. RESULTS: Rats were pretreated with varying i.v. doses of NicA2, followed by i.v. administration of nicotine at 0.03 mg/kg. NicA2 had a rapid onset of action reducing blood and brain nicotine concentrations in a dose-related manner, with a rapid onset of action. A 5 mg/kg NicA2 dose reduced the nicotine concentration in blood by > 90% at 1 min after the nicotine dose, compared to controls. Brain nicotine concentrations were reduced by 55% at 1 min and 92% at 5 min post nicotine dose. To evaluate enzyme effects at a nicotine dosing rate equivalent to heavy smoking, rats pretreated with NicA2 at 10 mg/kg were administered 5 doses of nicotine 0.03 mg/kg i.v. over 40 min. Nicotine levels in blood were below the assay detection limit 3 min after either the first or fifth nicotine dose, and nicotine levels in brain were reduced by 82 and 84%, respectively, compared to controls. A 20 mg/kg NicA2 dose attenuated nicotine discrimination and produced extinction of nicotine self-administration (NSA) in most rats, or a compensatory increase in other rats, when administered prior to each daily NSA session. In rats showing compensation, increasing the NicA2 dose to 70 mg/kg resulted in extinction of NSA. An enzyme construct with a longer duration of action, via fusion with an albumin-binding domain, similarly reduced NSA in a 23 h nicotine access model at a dose of 70 mg/kg. CONCLUSIONS: These data extend knowledge of NicA2’s effects on nicotine distribution to brain and its ability to attenuate addiction-relevant behaviors in rats and support its further investigation as a treatment for tobacco use disorder. BioMed Central 2018-07-24 /pmc/articles/PMC6056991/ /pubmed/30041697 http://dx.doi.org/10.1186/s12896-018-0457-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Pentel, Paul R.
Raleigh, Michael D.
LeSage, Mark G.
Thisted, Thomas
Horrigan, Stephen
Biesova, Zuzana
Kalnik, Matthew W.
The nicotine-degrading enzyme NicA2 reduces nicotine levels in blood, nicotine distribution to brain, and nicotine discrimination and reinforcement in rats
title The nicotine-degrading enzyme NicA2 reduces nicotine levels in blood, nicotine distribution to brain, and nicotine discrimination and reinforcement in rats
title_full The nicotine-degrading enzyme NicA2 reduces nicotine levels in blood, nicotine distribution to brain, and nicotine discrimination and reinforcement in rats
title_fullStr The nicotine-degrading enzyme NicA2 reduces nicotine levels in blood, nicotine distribution to brain, and nicotine discrimination and reinforcement in rats
title_full_unstemmed The nicotine-degrading enzyme NicA2 reduces nicotine levels in blood, nicotine distribution to brain, and nicotine discrimination and reinforcement in rats
title_short The nicotine-degrading enzyme NicA2 reduces nicotine levels in blood, nicotine distribution to brain, and nicotine discrimination and reinforcement in rats
title_sort nicotine-degrading enzyme nica2 reduces nicotine levels in blood, nicotine distribution to brain, and nicotine discrimination and reinforcement in rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056991/
https://www.ncbi.nlm.nih.gov/pubmed/30041697
http://dx.doi.org/10.1186/s12896-018-0457-7
work_keys_str_mv AT pentelpaulr thenicotinedegradingenzymenica2reducesnicotinelevelsinbloodnicotinedistributiontobrainandnicotinediscriminationandreinforcementinrats
AT raleighmichaeld thenicotinedegradingenzymenica2reducesnicotinelevelsinbloodnicotinedistributiontobrainandnicotinediscriminationandreinforcementinrats
AT lesagemarkg thenicotinedegradingenzymenica2reducesnicotinelevelsinbloodnicotinedistributiontobrainandnicotinediscriminationandreinforcementinrats
AT thistedthomas thenicotinedegradingenzymenica2reducesnicotinelevelsinbloodnicotinedistributiontobrainandnicotinediscriminationandreinforcementinrats
AT horriganstephen thenicotinedegradingenzymenica2reducesnicotinelevelsinbloodnicotinedistributiontobrainandnicotinediscriminationandreinforcementinrats
AT biesovazuzana thenicotinedegradingenzymenica2reducesnicotinelevelsinbloodnicotinedistributiontobrainandnicotinediscriminationandreinforcementinrats
AT kalnikmattheww thenicotinedegradingenzymenica2reducesnicotinelevelsinbloodnicotinedistributiontobrainandnicotinediscriminationandreinforcementinrats
AT pentelpaulr nicotinedegradingenzymenica2reducesnicotinelevelsinbloodnicotinedistributiontobrainandnicotinediscriminationandreinforcementinrats
AT raleighmichaeld nicotinedegradingenzymenica2reducesnicotinelevelsinbloodnicotinedistributiontobrainandnicotinediscriminationandreinforcementinrats
AT lesagemarkg nicotinedegradingenzymenica2reducesnicotinelevelsinbloodnicotinedistributiontobrainandnicotinediscriminationandreinforcementinrats
AT thistedthomas nicotinedegradingenzymenica2reducesnicotinelevelsinbloodnicotinedistributiontobrainandnicotinediscriminationandreinforcementinrats
AT horriganstephen nicotinedegradingenzymenica2reducesnicotinelevelsinbloodnicotinedistributiontobrainandnicotinediscriminationandreinforcementinrats
AT biesovazuzana nicotinedegradingenzymenica2reducesnicotinelevelsinbloodnicotinedistributiontobrainandnicotinediscriminationandreinforcementinrats
AT kalnikmattheww nicotinedegradingenzymenica2reducesnicotinelevelsinbloodnicotinedistributiontobrainandnicotinediscriminationandreinforcementinrats